ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,586, issued on May 27, was assigned to Empirico Inc. (San Diego).
"Treatment of MST1 related diseases and disorders" was invented by Omri Gottesman (San Diego), Shannon Bruse (San Diego), Paul Buske (Madison, Wis.), Brian Cajes (San Diego), David Jakubosky (San Diego), Sarah Kleinstein (San Diego), David Lewis (Madison, Wis.), David Rozema (Cross Plains, Wis.) and John Vekich (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions comprising an oligonucleotide that targets MST1. The oligonucleotide may include a small interfering RNA (siRNA) or an antisense oligonucleotide (ASO). Also provided herein are methods o...